2 research outputs found
Patient-reported scar quality of adults after burn injuries: A five-year multicenter follow-up study
Scar formation is an important adverse consequence of burns. How patients
appraise their scar quality is often studied shortly after sustaining the injury, but
information in the long-term is scarce. Our aim was, therefore, to evaluate longterm patient-reported quality of burn scars. Adults with a burn center admission
of ≥1 day between August 2011 and September 2012 were invited to complete a
questionnaire on long-term consequences of burns. We enriched this sample with
patients with severe burns (>20% total body surface area [TBSA] burned or TBSA
full thickness >5%) treated between January 2010 and March 2013. Self-reported
scar quality was assessed with the Patient Scale of the Patient and Observer Scar
Assessment Scale (POSAS). Patients completed this scale for their—in their
opinion—most severe scar ≥5 years after burns. This study included 251 patients
with a mean %TBSA burned of 10%. The vast majority (91.4%) reported at least
minor differences with normal skin (POSAS item score ≥2) on one or more scar
characteristics and 78.9% of the patients’ overall opinion was that their scar deviated from normal skin. Patients with severe burns had higher POSAS scores, representing worse scar quality, than patients with mild/intermediate burns, except for
color, which was high in both groups. A longer hospital stay predicted reduced scar
quality (both mean POSAS and mean overall opinion of the scar) in multivariate
analyses. In addition, female gender was also associated with a poorer overall opinion of the scar. In conclusion, this study provides new insights in long-term scar
quality. Scars differed from normal skin in a large part of the burn population more
than 5 years after burns, especially in those with severe burns. Female gender is
associated with a poorer patients’ overall opinion of their scar, which may be an
indication of gender differences in perception of scar quality after burns
Colorectal cancer risk variants at 8q23.3 and 11q23.1 are associated with disease phenotype in APC mutation carriers
Contains fulltext :
167193.pdf (publisher's version ) (Open Access)Familial adenomatous polyposis (FAP) is a dominantly inherited syndrome caused by germline mutations in the APC gene and characterized by the development of multiple colorectal adenomas and a high risk of developing colorectal cancer (CRC). The severity of polyposis is correlated with the site of the APC mutation. However, there is also phenotypic variability within families with the same underlying APC mutation, suggesting that additional factors influence the severity of polyposis. Genome-wide association studies identified several single nucleotide polymorphisms (SNPs) that are associated with CRC. We assessed whether these SNPs are associated with polyp multiplicity in proven APC mutation carriers. Sixteen CRC-associated SNPs were analysed in a cohort of 419 APC germline mutation carriers from 182 families. Clinical data were retrieved from the Dutch Polyposis Registry. Allele frequencies of the SNPs were compared for patients with /=100 adenomas, using generalized estimating equations with the APC genotype as a covariate. We found a trend of association of two of the tested SNPs with the >/=100 adenoma phenotype: the C alleles of rs16892766 at 8q23.3 (OR 1.71, 95 % CI 1.05-2.76, p = 0.03, dominant model) and rs3802842 at 11q23.1 (OR 1.51, 95 % CI 1.03-2.22, p = 0.04, dominant model). We identified two risk variants that are associated with a more severe phenotype in APC mutation carriers. These risk variants may partly explain the phenotypic variability in families with the same APC gene defect. Further studies with a larger sample size are recommended to evaluate and confirm the phenotypic effect of these SNPs in FAP